annual EBITDA:
-$493.48M-$36.80M(-8.06%)Summary
- As of today (July 1, 2025), CYTK annual EBITDA is -$493.48 million, with the most recent change of -$36.80 million (-8.06%) on December 31, 2024.
- During the last 3 years, CYTK annual EBITDA has fallen by -$309.78 million (-168.63%).
- CYTK annual EBITDA is now -1919.36% below its all-time high of $27.12 million, reached on December 31, 2009.
Performance
CYTK EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly EBITDA:
-$136.13M-$11.09M(-8.87%)Summary
- As of today (July 1, 2025), CYTK quarterly EBITDA is -$136.13 million, with the most recent change of -$11.09 million (-8.87%) on March 1, 2025.
- Over the past year, CYTK quarterly EBITDA has dropped by -$20.14 million (-17.36%).
- CYTK quarterly EBITDA is now -340.59% below its all-time high of $56.58 million, reached on June 30, 2009.
Performance
CYTK quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
-$513.62M-$20.14M(-4.08%)Summary
- As of today (July 1, 2025), CYTK TTM EBITDA is -$513.62 million, with the most recent change of -$20.14 million (-4.08%) on March 1, 2025.
- Over the past year, CYTK TTM EBITDA has dropped by -$57.15 million (-12.52%).
- CYTK TTM EBITDA is now -1868.49% below its all-time high of $29.04 million, reached on September 30, 2009.
Performance
CYTK TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
CYTK EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -8.1% | -17.4% | -12.5% |
| 3 y3 years | -168.6% | -72.8% | -130.6% |
| 5 y5 years | -430.4% | -362.8% | -391.4% |
CYTK EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -168.6% | at low | -1482.3% | at low | -189.8% | at low |
| 5 y | 5-year | -468.6% | at low | -2102.5% | at low | -583.4% | at low |
| alltime | all time | -1919.4% | at low | -340.6% | at low | -1868.5% | at low |
CYTK EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | -$136.13M(+8.9%) | -$513.62M(+4.1%) |
| Dec 2024 | -$493.48M(+8.1%) | -$125.04M(-7.9%) | -$493.48M(+2.4%) |
| Sep 2024 | - | -$135.84M(+16.5%) | -$481.94M(+4.8%) |
| Jun 2024 | - | -$116.61M(+0.5%) | -$459.67M(+0.7%) |
| Mar 2024 | - | -$115.99M(+2.2%) | -$456.48M(-0.0%) |
| Dec 2023 | -$456.68M(+37.6%) | -$113.50M(-0.1%) | -$456.68M(-1.3%) |
| Sep 2023 | - | -$113.57M(+0.1%) | -$462.64M(-2.4%) |
| Jun 2023 | - | -$113.42M(-2.4%) | -$474.20M(+28.4%) |
| Mar 2023 | - | -$116.20M(-2.7%) | -$369.39M(+11.3%) |
| Dec 2022 | -$331.99M(+80.7%) | -$119.45M(-4.5%) | -$331.99M(+41.9%) |
| Sep 2022 | - | -$125.14M(+1354.6%) | -$233.88M(+31.9%) |
| Jun 2022 | - | -$8.60M(-89.1%) | -$177.25M(-20.4%) |
| Mar 2022 | - | -$78.79M(+269.1%) | -$222.72M(+21.2%) |
| Dec 2021 | -$183.71M(+111.7%) | -$21.35M(-68.8%) | -$183.71M(-6.3%) |
| Sep 2021 | - | -$68.51M(+26.7%) | -$195.97M(+62.4%) |
| Jun 2021 | - | -$54.07M(+35.9%) | -$120.66M(+24.2%) |
| Mar 2021 | - | -$39.78M(+18.4%) | -$97.15M(+11.9%) |
| Dec 2020 | -$86.78M(-6.7%) | -$33.61M(-594.4%) | -$86.78M(+15.5%) |
| Sep 2020 | - | $6.80M(-122.2%) | -$75.16M(-28.1%) |
| Jun 2020 | - | -$30.56M(+3.9%) | -$104.53M(+5.2%) |
| Mar 2020 | - | -$29.41M(+33.8%) | -$99.36M(+6.8%) |
| Dec 2019 | -$93.04M(+11.4%) | -$21.98M(-2.6%) | -$93.04M(+1.6%) |
| Sep 2019 | - | -$22.57M(-11.1%) | -$91.61M(+7.3%) |
| Jun 2019 | - | -$25.39M(+10.0%) | -$85.36M(+4.6%) |
| Mar 2019 | - | -$23.09M(+12.3%) | -$81.64M(-1.8%) |
| Dec 2018 | -$83.49M(-23.3%) | -$20.56M(+25.9%) | -$83.17M(-14.9%) |
| Sep 2018 | - | -$16.32M(-24.7%) | -$97.75M(-10.0%) |
| Jun 2018 | - | -$21.67M(-12.0%) | -$108.62M(-2.2%) |
| Mar 2018 | - | -$24.62M(-30.0%) | -$111.10M(+2.0%) |
| Dec 2017 | -$108.87M(-647.3%) | -$35.14M(+29.2%) | -$108.88M(+65.9%) |
| Sep 2017 | - | -$27.20M(+12.6%) | -$65.64M(+1466.5%) |
| Jun 2017 | - | -$24.14M(+7.8%) | -$4.19M(-145.4%) |
| Mar 2017 | - | -$22.39M(-376.7%) | $9.22M(-53.7%) |
| Dec 2016 | $19.89M(-154.3%) | $8.09M(-76.4%) | $19.89M(+565.9%) |
| Sep 2016 | - | $34.25M(-419.1%) | $2.99M(-107.5%) |
| Jun 2016 | - | -$10.73M(-8.4%) | -$39.97M(+0.7%) |
| Mar 2016 | - | -$11.72M(+33.1%) | -$39.68M(+8.1%) |
| Dec 2015 | -$36.64M(+158.9%) | -$8.81M(+1.2%) | -$36.72M(+90.8%) |
| Sep 2015 | - | -$8.70M(-16.7%) | -$19.24M(+17.2%) |
| Jun 2015 | - | -$10.44M(+19.1%) | -$16.41M(+15.1%) |
| Mar 2015 | - | -$8.76M(-201.1%) | -$14.26M(+0.7%) |
| Dec 2014 | -$14.16M(-57.5%) | $8.67M(-247.6%) | -$14.16M(-12.2%) |
| Sep 2014 | - | -$5.87M(-29.1%) | -$16.13M(-29.2%) |
| Jun 2014 | - | -$8.29M(-4.4%) | -$22.76M(-22.6%) |
| Mar 2014 | - | -$8.66M(-229.4%) | -$29.43M(-11.6%) |
| Dec 2013 | -$33.28M | $6.70M(-153.5%) | -$33.28M(-35.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2013 | - | -$12.51M(-16.3%) | -$51.31M(+5.4%) |
| Jun 2013 | - | -$14.95M(+19.4%) | -$48.70M(+14.4%) |
| Mar 2013 | - | -$12.52M(+10.6%) | -$42.58M(+7.0%) |
| Dec 2012 | -$39.78M(-14.5%) | -$11.33M(+14.4%) | -$39.80M(-0.8%) |
| Sep 2012 | - | -$9.90M(+12.2%) | -$40.12M(-1.2%) |
| Jun 2012 | - | -$8.82M(-9.5%) | -$40.59M(-9.8%) |
| Mar 2012 | - | -$9.75M(-16.3%) | -$45.00M(-3.3%) |
| Dec 2011 | -$46.52M(-1.8%) | -$11.64M(+12.2%) | -$46.52M(+1.1%) |
| Sep 2011 | - | -$10.38M(-21.6%) | -$46.01M(-3.5%) |
| Jun 2011 | - | -$13.23M(+17.3%) | -$47.66M(+1.3%) |
| Mar 2011 | - | -$11.27M(+1.3%) | -$47.04M(-0.8%) |
| Dec 2010 | -$47.40M(-274.8%) | -$11.13M(-7.5%) | -$47.40M(-1.4%) |
| Sep 2010 | - | -$12.03M(-4.5%) | -$48.06M(+10.2%) |
| Jun 2010 | - | -$12.61M(+8.4%) | -$43.63M(-270.7%) |
| Mar 2010 | - | -$11.63M(-1.4%) | $25.56M(-5.8%) |
| Dec 2009 | $27.12M(-150.8%) | -$11.79M(+55.3%) | $27.12M(-6.6%) |
| Sep 2009 | - | -$7.59M(-113.4%) | $29.04M(+26.1%) |
| Jun 2009 | - | $56.58M(-661.9%) | $23.04M(-147.1%) |
| Mar 2009 | - | -$10.07M(+2.0%) | -$48.95M(-8.4%) |
| Dec 2008 | -$53.43M(-0.4%) | -$9.87M(-27.4%) | -$53.43M(-7.7%) |
| Sep 2008 | - | -$13.60M(-11.7%) | -$57.85M(+1.9%) |
| Jun 2008 | - | -$15.40M(+5.8%) | -$56.78M(+2.9%) |
| Mar 2008 | - | -$14.55M(+1.8%) | -$55.20M(+2.9%) |
| Dec 2007 | -$53.66M(-8.1%) | -$14.30M(+14.1%) | -$53.66M(-3.6%) |
| Sep 2007 | - | -$12.53M(-9.3%) | -$55.63M(-4.7%) |
| Jun 2007 | - | -$13.82M(+6.2%) | -$58.38M(-0.6%) |
| Mar 2007 | - | -$13.01M(-20.1%) | -$58.70M(+0.5%) |
| Dec 2006 | -$58.41M(+40.5%) | -$16.27M(+6.5%) | -$58.41M(+10.0%) |
| Sep 2006 | - | -$15.28M(+8.0%) | -$53.09M(+11.1%) |
| Jun 2006 | - | -$14.14M(+11.2%) | -$47.78M(+8.7%) |
| Mar 2006 | - | -$12.72M(+16.1%) | -$43.97M(+5.8%) |
| Dec 2005 | -$41.57M(+18.2%) | -$10.95M(+9.9%) | -$41.57M(-1.2%) |
| Sep 2005 | - | -$9.97M(-3.5%) | -$42.09M(+0.3%) |
| Jun 2005 | - | -$10.33M(+0.1%) | -$41.95M(+4.0%) |
| Mar 2005 | - | -$10.32M(-10.1%) | -$40.33M(+14.7%) |
| Dec 2004 | -$35.16M(+19.5%) | -$11.47M(+16.7%) | -$35.16M(-45.2%) |
| Sep 2004 | - | -$9.83M(+12.9%) | -$64.21M(+24.1%) |
| Jun 2004 | - | -$8.71M(+69.1%) | -$51.73M(+8.3%) |
| Mar 2004 | - | -$5.15M(-87.3%) | -$47.76M(+0.3%) |
| Dec 2003 | -$29.41M(+39.2%) | -$40.52M(-1632.6%) | -$47.62M(+571.1%) |
| Sep 2003 | - | $2.64M(-155.9%) | -$7.09M(-27.1%) |
| Jun 2003 | - | -$4.73M(-5.5%) | -$9.74M(+94.5%) |
| Mar 2003 | - | -$5.01M | -$5.01M |
| Dec 2002 | -$21.13M(+14.9%) | - | - |
| Dec 2001 | -$18.39M(+33.3%) | - | - |
| Dec 2000 | -$13.79M | - | - |
FAQ
- What is Cytokinetics Incorporated annual EBITDA?
- What is the all time high annual EBITDA for Cytokinetics Incorporated?
- What is Cytokinetics Incorporated annual EBITDA year-on-year change?
- What is Cytokinetics Incorporated quarterly EBITDA?
- What is the all time high quarterly EBITDA for Cytokinetics Incorporated?
- What is Cytokinetics Incorporated quarterly EBITDA year-on-year change?
- What is Cytokinetics Incorporated TTM EBITDA?
- What is the all time high TTM EBITDA for Cytokinetics Incorporated?
- What is Cytokinetics Incorporated TTM EBITDA year-on-year change?
What is Cytokinetics Incorporated annual EBITDA?
The current annual EBITDA of CYTK is -$493.48M
What is the all time high annual EBITDA for Cytokinetics Incorporated?
Cytokinetics Incorporated all-time high annual EBITDA is $27.12M
What is Cytokinetics Incorporated annual EBITDA year-on-year change?
Over the past year, CYTK annual EBITDA has changed by -$36.80M (-8.06%)
What is Cytokinetics Incorporated quarterly EBITDA?
The current quarterly EBITDA of CYTK is -$136.13M
What is the all time high quarterly EBITDA for Cytokinetics Incorporated?
Cytokinetics Incorporated all-time high quarterly EBITDA is $56.58M
What is Cytokinetics Incorporated quarterly EBITDA year-on-year change?
Over the past year, CYTK quarterly EBITDA has changed by -$20.14M (-17.36%)
What is Cytokinetics Incorporated TTM EBITDA?
The current TTM EBITDA of CYTK is -$513.62M
What is the all time high TTM EBITDA for Cytokinetics Incorporated?
Cytokinetics Incorporated all-time high TTM EBITDA is $29.04M
What is Cytokinetics Incorporated TTM EBITDA year-on-year change?
Over the past year, CYTK TTM EBITDA has changed by -$57.15M (-12.52%)